跳至主要内容
临床试验/NCT05072912
NCT05072912终止不适用

Screening Study to Identify Patients With Complement Factor I Deficiencies

Catalyst Biosciences1 个研究点 分布在 1 个国家目标入组 113 人开始时间: 2021年7月21日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
113
试验地点
1
主要终点
Complement Factor I Deficiency Identification

研究概览

简要总结

This is screening study to identify patients with Complement Factor I deficiencies. The primary objective is to identify participants with CFI deficiencies and assess the prevalence in the screened population.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
6 Months 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • An individual must meet all the following criteria to be eligible to participate in this study:
  • A male or female ≥6 months of age who has been diagnosed with a complement-mediated disease in which a reasonable etiological association with CFI deficiency has been reported
  • Affirmation of participant's informed consent or LAR's willingness to provide informed consent with signature confirmation before any study-related activities. (Study-related activities are any procedures that would not have been performed during normal clinical management of the participant.) The participant (if a minor) must be willing to give written informed assent if the minor is within the age groups 7 to 11 years old and 12 to 17 years old.

排除标准

  • Diagnosis of age-related macular degeneration that is complement-related with no concurrent systemic complement involvement

结局指标

主要结局

Complement Factor I Deficiency Identification

时间窗: At Screening

Identification of participants with a CFI deficiency and percentage of those with a CFI deficiency versus total number of screened participants

次要结局

  • Demographics, Disease Characteristics, Medication Use(At Screening)

研究者

发起方
Catalyst Biosciences
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验